6Suppliers
4Customers
3Debt Items
20Related Chains

eXoZymes, Inc. Suppliers

TickerNameConfidenceEvidence
MDB-CAPITAL MDB-CAPITAL 92% the Company agreed to issue and sell, in a firm commitment underwritten offering (the “Offering”) an aggregate of 592,270 shares of common stock (the “Shares”), $0.000001 par value per share (the “Co…
THE-REGENTS THE-REGENTS 92% The payments made to the Regents in connection with our license agreement with the Regents, from 2019 to March 31, 2026, have aggregated $ 408,338
MRK Merck & Co., Inc. 72% ● predictable, single-product precision without undesired by-products. The technology delivers >99% food/pharma-grade purity, simplifying formulation and regulatory readiness. Because the process run…
MRK Merck & Co., Inc. 72% Reciprocal relationship from MRK graph: Reciprocal relationship from EXOZ graph: ● predictable, single-product precision without undesired by-products. The technology delivers >99% food/pharma-grade …
VLO Valero Energy Corporation 72% ● predictable, single-product precision without undesired by-products. The technology delivers >99% food/pharma-grade purity, simplifying formulation and regulatory readiness. Because the process run…
VLO Valero Energy Corporation 72% Reciprocal relationship from VLO graph: Reciprocal relationship from EXOZ graph: ● predictable, single-product precision without undesired by-products. The technology delivers >99% food/pharma-grade …

eXoZymes, Inc. Customers

TickerNameConfidenceEvidence
MRK Merck & Co., Inc. 72% lly owned purpose built subsidiary – initially 100% owned by eXoZymes) If and when we identify a business opportunity (via a specific market application for one of our exozyme biosolutions), we plan …
MRK Merck & Co., Inc. 72% Reciprocal relationship from MRK graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from MRK graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from MRK grap…
VLO Valero Energy Corporation 72% lly owned purpose built subsidiary – initially 100% owned by eXoZymes) If and when we identify a business opportunity (via a specific market application for one of our exozyme biosolutions), we plan …
VLO Valero Energy Corporation 72% Reciprocal relationship from VLO graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from VLO graph: Reciprocal relationship from EXOZ graph: lly owned purpose built subsidiary – …

eXoZymes, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
EXOZ-DEBT-9415 Warrants outstanding: 11819 90% xbrl warrant detail from xbrl 2025-12-31.
EXOZ-DEBT Debt stack $1.2M 90% Market cache reports total debt of $1.2M.
EXOZ-DEBT-9416 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

eXoZymes, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for eXoZymes, Inc..

eXoZymes, Inc. Ownership

HolderNameConfidenceEvidence
EXOZ-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 7 tracked holders.

eXoZymes, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
VLO Valero Energy Corporation 100.00 1 ['customer', 'supplier']
MRK Merck & Co., Inc. 100.00 1 ['customer', 'supplier']
BNBX BNB Plus Corp. 50.00 2
AVIR Atea Pharmaceuticals, Inc. 50.00 2
IMMP Immutep Limited 50.00 2
CYTK Cytokinetics, Incorporated 50.00 2
PSNL Personalis, Inc. 50.00 2
EVFM Evofem Biosciences, Inc. 50.00 2
EDSA Edesa Biotech, Inc. 50.00 2
DYN Dyne Therapeutics, Inc. 50.00 2
TALO Talos Energy Inc. 50.00 2
SLS SELLAS Life Sciences Group, Inc. 50.00 2
ORANY ORANGE 50.00 2
GYRE Gyre Therapeutics, Inc. 50.00 2
SDGR Schrödinger, Inc. 50.00 2
CBIH Cannabis Bioscience International Holdings, Inc. 50.00 2
ADAG Adagene Inc. 50.00 2
SRE Sempra 50.00 2
ELAN Elanco Animal Health Incorporated 50.00 2
DKS DICK'S Sporting Goods, Inc. 50.00 2